BOSTON SCIENTIFIC CORPORATION Restricted Cash and Cash Equivalents, Noncurrent
BOSTON SCIENTIFIC CORPORATION (BSX) had Restricted Cash and Cash Equivalents, Noncurrent of $31.00 million as of 2018-06-30, per its 10-Q filed 2018-07-31.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2018-07-31
- 2018-06-30: Restricted Cash and Cash Equivalents, Noncurrent $31.00M.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $26.00M.
- 2017-06-30: Restricted Cash and Cash Equivalents, Noncurrent $27.00M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2018-06-30 | $31.00M 10-Q · filed 2018-07-31 |
| 2017-12-31 | $26.00M 10-Q · filed 2018-07-31 |
| 2017-06-30 | $27.00M 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |